Company news
Infield Minerals Corp (TSXV:IN) news
Infield Minerals Corp news releases on 6ix. Latest, Dec 18, 2017: NetworkNewsWire Announces Publication on the Value of Cannabinoid-based Alternatives…
Press releases — page 4
NetworkNewsWire Announces Publication on the Value of Cannabinoid-based Alternatives to Opioids
December 18, 2017
Horizons ETFs Expands the Portfolio of its Marijuana-Focused ETF
December 18, 2017
NetworkNewsWire Announces Publication Discussing Advances in Cannabinoid-Based Therapies
December 14, 2017
NetworkNewsWire Announces Publication Discussing Advances in Cannabinoids for use in Pain Management
December 11, 2017
NetworkNewsWire Announces Publication Discussing Advances in the Manufacture of Cannabinoid Compounds for Medical Purposes
December 7, 2017
NetworkNewsWire Announces Publication on Innovative Research Being Developed on Cannabinoid-Based Therapies, Drugs
November 17, 2017
NetworkNewsWire Announces Publication Discussing Biotech Advances in Cannabis Research
November 16, 2017
InMed to Present at Cannabis-Based Science & Medicine Conference
November 16, 2017
NetworkNewsWire Announces Publication Discussing M&A Activity Driven by the Convergence of Cannabis and Medicine
November 9, 2017
CFN Media Exclusive CEO Interview: InMed Pharmaceuticals' Biosynthesis Platform Results in an Industry First
November 6, 2017
NetworkNewsWire Announces Publication Discussing Innovative Extraction Methods Used in the Production of Cannabinoids
November 2, 2017
NetworkNewsWire Announces Publication Discussing Unique R&D in the Medicinal Marijuana Industry
October 30, 2017
NetworkNewsWire Announces Publication Highlighting Advances in CBD Development
October 30, 2017
NetworkNewsWire Announces Publication on Biosynthesis for Medicinal-Grade Cannabinoids
October 26, 2017
InMed Announces Positive Pre-Clinical Data on an Ocular Hydrogel Formulation using a Biosynthesized Cannabinoid
October 24, 2017
InMed Updates Pain Program
October 17, 2017
InMed Appoints Dr. Mauro Maccarrone to its Scientific Advisory Board
October 10, 2017
NetworkNewsWire Announces Publication that Highlights the Limitless Potential of Innovative Drug Development
October 3, 2017
InMed Pharmaceuticals Files Provisional Patent for Pain Program
October 3, 2017
NetworkNewsWire Announces Publication Highlighting Unique Technology in Cannabinoid-Based Medicine
September 28, 2017
InMed Continues to Make Significant Strides on Biosynthesis Program Development
September 25, 2017
InMed Pharmaceuticals Added to CSE25 Index
September 21, 2017
InMed Retains Consultant Ben Paterson for Biosynthesis Development
September 19, 2017
Canadian Securities Exchange Launches CSE25 Index
September 18, 2017
NetworkNewsWire Announces Publication on Innovations Set to Disrupt the Cannabis Industry
September 15, 2017
InMed Files Provisional Patent for Biosynthesis of Cannabinoids
September 12, 2017
InMed Announces Appointment of Creative Capital Media
August 18, 2017
InMed Announces Publication in European Journal of Pain
July 27, 2017
InMed Signs R&D Agreement with ATERA
July 10, 2017
InMed Announces Agreement to Advance a Topical Formulation of INM-750
June 13, 2017
InMed Raises $5.75 Million Through Underwritten Financing Including Full Exercise of the Over-Allotment Option
May 31, 2017
InMed Announces Pricing of $5,004,000 Underwritten Financing
May 23, 2017
InMed Pharmaceuticals Files Provisional Patent Application for Ophthalmic Drug Delivery
May 10, 2017
InMed Receives over $1,350,000 From Warrant Exercise
February 27, 2017
InMed Pharmaceuticals to Present at the 2017 BIO CEO & Investor Conference
February 9, 2017
InMed Pharmaceuticals, Inc. Closes Non-Brokered Private Placement for C$1,500,000
January 18, 2017
InMed Pharmaceuticals Appoints Martin Bott to Board of Directors
January 13, 2017
InMed Provides 2016 Year End Update
December 23, 2016
InMed Pharmaceuticals Announces Appointment of Veteran Biotech CFO, Jeff Charpentier
December 15, 2016
InMed announces progress on COPD program
December 6, 2016
InMed Pharmaceuticals, Inc. Appoints Senior Vice President, Clinical and Regulatory Affairs
October 31, 2016
InMed Appoints Andrew Hull to the Board of Directors
September 13, 2016
InMed to Present at 18th Annual Rodman and Renshaw Global Investment Conference
September 12, 2016
InMed Pharmaceuticals Inc. Announces Non-Brokered Private Placement - Video News Alert on InvestmentPitch.com
November 6, 2015
InMed Pharmaceuticals Files Provisional Patent Application for Treating Eye Disease - Video News Alert on InvestmentPitch.com
May 13, 2015
InMed Pharmaceuticals to Present Investor Webcast March 5
March 2, 2015
Cannabis Technologies Lists on Canadian Securities Exchange - Video News Alert on Investmentpitch.com
May 22, 2014